Clinical Practice

Global resource developed for osteoporosis self management

March 17, 2026 / Clinical Practice / InnovateMed Author / osteoporosis

by International Osteoporosis Foundation edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source The Build Better Bones platform is a multilingual website created to support self-management for people living with osteoporosis and their care partners. https://www.buildbetterbones.org. Credit: International Osteoporosis Foundation A new paper published in Osteoporosis International describes the rigorous, user-centered development of “Build Better […]

Global resource developed for osteoporosis self management Read More »

New findings suggest symptom patterns may help diagnose Alzheimer’s with FTLD

March 17, 2026 / Clinical Practice / InnovateMed Author / alzheimer

by Corrie Pikul, Brown University edited by Stephanie Baum, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: SHVETS production from Pexels People with Alzheimer’s disease often have other neurodegenerative conditions as well, including a less-understood disorder called frontotemporal lobar degeneration (FTLD). While a precise diagnosis of FTLD has only been possible during an

New findings suggest symptom patterns may help diagnose Alzheimer’s with FTLD Read More »

Largest-ever Parkinson’s study shows how symptoms differ between men and women

March 17, 2026 / Clinical Practice / InnovateMed Author / parkinson

by Lyndsey Collins-Praino, The Conversation edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Parkinson’s disease is the fastest growing neurological disorder, with more than 10 million cases worldwide. Up to 150,000 Australians currently live with the disease and 50 new cases are diagnosed each day. The number of people living

Largest-ever Parkinson’s study shows how symptoms differ between men and women Read More »

The hidden signals of Crohn’s disease: Why remission is not recovery

March 17, 2026 / Clinical Practice / InnovateMed Author / Crohn's disease

by Yael Haberman edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Summary of the incomplete recovery of gut signals during Crohn’s disease remission. Credit: Gastroenterology (2026). DOI: 10.1053/j.gastro.2025.12.007 Imagine a patient with Crohn’s disease—after months of flares, they are finally in clinical remission. Their biomarkers are stable, their pain has subsided,

The hidden signals of Crohn’s disease: Why remission is not recovery Read More »

New video series boosts safe psychotropic use in aged care

March 17, 2026 / Clinical Practice / InnovateMed Author / Psychotropic

by Monash University edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Matthias Zomer from Pexels Researchers at Monash University and Flinders University have launched a series of microlearning education videos designed to support safer, more appropriate use of psychotropic medications for people living with dementia and in residential aged

New video series boosts safe psychotropic use in aged care Read More »

A first-of-its-kind tool helps Parkinson’s patients decide if deep brain stimulation is right for them

March 17, 2026 / Clinical Practice / InnovateMed Author / parkinson

by Julia Milzer, CU Anschutz Medical Campus edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson’s disease. While DBS is one of the most effective interventions for movement symptoms, it’s

A first-of-its-kind tool helps Parkinson’s patients decide if deep brain stimulation is right for them Read More »

THE MISSING CHIP

March 16, 2026 / Clinical Practice / InnovateMed Author / CHIP

Ignoring a very informative lab test Eric Topol Mar 15, 2026 It took 8 years for the cardiology professional organizations to revise their guidelines to align with the evidence-based lipid panel, published this week, finally incorporating lipoprotein(a) —Lp(a) and Apolipoprotein B—ApoB. Think of how many people would have been identified at high-risk for atherosclerosis and cardiovascular events

THE MISSING CHIP Read More »

Rhythm-training game played to music on a cell phone shows promise for reducing stuttering in children

March 16, 2026 / Clinical Practice / InnovateMed Author / stuttering

by Béatrice St-Cyr-Leroux, University of Montreal edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source The concept of Rhythm Workers is simple: players tap the screen of a cellphone in time with the music being played, building virtual structures as their accuracy improves. Credit: BEATHEALTH Stuttering is more than just struggling

Rhythm-training game played to music on a cell phone shows promise for reducing stuttering in children Read More »

Pregnancy changes the brain, and we are only beginning to understand how and why

March 16, 2026 / Clinical Practice / InnovateMed Author / pregnancy changes

by Birgit Derntl, Ann-Christin S. Kimmig, Franziska Weinmar, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Millions of women go through pregnancy every year, yet science has only just begun to look at what it does to the brain—the organ undergoing perhaps the most

Pregnancy changes the brain, and we are only beginning to understand how and why Read More »

FDA warns Novo Nordisk broke safety reporting rules

March 16, 2026 / Clinical Practice / InnovateMed Author / nordisk

by HealthDay Staff edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government. In a March 5 warning letter, the U.S. Food and Drug Administration (FDA) said Novo Nordisk committed

FDA warns Novo Nordisk broke safety reporting rules Read More »